Prefilled Syringes Market Rise In Prevalence Of Chronic Diseases Globally 2025 Estimated By Global Key Players Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporatio

The prefilled syringes are one of the fastest growing choices for the unit dose delivery and has emerged as one of the most convenient way of drug delivery method in the recent years. The extensive use of prefilled syringes has enabled the pharmaceutical companies to minimize drug-wastage and increase the life-span of the product at the same time. The plastic disposable syringes has created a revolution in the healthcare market which has been enhanced by the introduction of sterile prefilled syringes that enables safe self-administration of injectable drugs to patients sitting at home without a need to visit hospitals. According to National Center for Biotechnology Information (NCBI), 25% of expenditure on drugs goes unused and wasted in the United States while 3-7% of medications intended towards patients goes unused. These massive revenues could be directed in a useful way with the use of prefilled syringes in the market that enables to improve the shelf life of the drugs as well as avoids wastage of drugs as the syringes are filled with exact volume and concentration of the drug that will deliver optimum results. Prefilled syringes make a profitable deal for the pharmaceutical companies too, as these companies can be benefitted from the less over-fill of drugs as compared to the vials that serves to be an important advantage, particularly in case of costly biopharmaceuticals.

Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/162

Market Dynamics:

Minimum environment exposure, easy administration, better patient compliance and 100% bioavailability are the factors expected to drive the prefilled syringes market growth in the forecast period. According to the World Journal of Pharmacy and Pharmaceutical Sciences 2016, more than 3.5 billion prefilled syringes are produced and used annually by patients and healthcare providers for the treatment of broad spectrum of conditions. The technological innovations and developments of prefilled syringes are contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for the biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, availability of alternative systems such as nanopatches, microneedles, connected delivery devices, limited shelf life and stability issues of the drugs are the factors restraining the market growth.

Market Taxonomy:

This report segments the global prefilled syringes market on the basis of drug type, material and geography. On the basis of product type, the prefilled syringes market is categorized into biologics, vaccines, insulin and others. Biologics are further categorized into monoclonal antibodies, blood products and others. Vaccines are further categorized into conjugated vaccines, live attenuated vaccines, recombinant vaccines and others. On the basis of material, the prefilled syringes market is categorized into glass and plastic/polymer. For comprehensive understanding of market dynamics, the global prefilled syringes market is analyzed across key geographical regions namely North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key players indulged in strategic implementation of various policies for the stabilization of prefilled syringes as well as to encounter other issues associated with it;

• In 2015, Gerresheimer and Corning Inc. signed a joint venture in order to accelerate the innovations for pharmaceutical glass packaging materials. The companies entered into a 10 year supply agreement for borosilicate glass tubes focusing on packaging of pharmaceutical products.

• In 2016, BESPAK launched SYRINA AR 2.25 auto injector that enables fully-automatic delivery of viscous drug formulations. The innovative auto-injector is specifically tailored to inject higher viscosities enabling safe use of glass syringes.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/162

Detailed Segmentation:

• Global Prefilled Syringes Market, By Drug Type:
Biologics
- Monoclonal Antibodies
- Blood Products
- Others

Vaccines
- Conjugated Vaccines
- Live Attenuated Vaccines
- Recombinant vaccines
- Others

Insulin
Others

• Global Prefilled Syringes Market, By Material:
Glass
Plastic & Polymer

• Global Prefilled Syringes Market, By Geography:
North America
Europe
Asia-Pacific
Latin America
Middle East
Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.